Chipitsyna Galina, Gong Qiaoke, Gray Chance F, Haroon Yasir, Kamer Erdinc, Arafat Hwyda A
Department of Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Endocrinology. 2007 May;148(5):2198-208. doi: 10.1210/en.2006-1358. Epub 2007 Feb 15.
Angiotensin II (AngII), the principal hormone of the renin-angiotensin system, is actively generated in the pancreas and has been suggested as a key mediator of inflammation. Monocyte chemoattractant protein-1 (MCP-1) is a chemokine that plays an important role in the recruitment of mononuclear cells into the pancreatic islets. In this study, we investigated the potential molecular basis for the role of AngII in islet inflammation through studying its effect on MCP-1. AngII significantly increased the expression of MCP-1 mRNA and protein in the RINm5F beta-cell line and activated MCP-1 promoter. AngII-MCP-1 mRNA induction was inhibited by an AngII type 1 receptor antagonist but was unchanged by an AngII type 2 receptor antagonist. AngII-MCP-1 induction was inhibited by the tyrosine kinase inhibitor genistein, suggesting a MAPK signaling mechanism. AngII activated the phosphorylation of ERK1/2 but not p38 or c-Jun NH(2)-terminal MAPKs. Inhibition of ERK1/2 activation reduced the AngII-induced MCP-1 synthesis. In nonobese diabetic mice pancreata, the temporal pattern of angiotensin-converting enzyme expression correlated well with progression of insulitis and beta-cell destruction. Immunostaining of pancreatic serial sections show colocalization of angiotensin-converting enzyme with MCP-1 in beta-cells in the islets. In freshly isolated islets from normoglycemic mice, AngII alone and in combination with IL-1beta elicited an inflammatory response by stimulation of MCP-1. Our data suggest a positive autocrine/paracrine action for the local pancreatic AngII-generating system during insulitis and provide the first insight into an AngII-initiated signal transduction pathway that regulates MCP-1 as a possible inflammatory mechanism in the islets.
血管紧张素II(AngII)是肾素-血管紧张素系统的主要激素,在胰腺中活跃生成,并被认为是炎症的关键介质。单核细胞趋化蛋白-1(MCP-1)是一种趋化因子,在单核细胞募集到胰岛中起重要作用。在本研究中,我们通过研究AngII对MCP-1的影响,探讨了AngII在胰岛炎症中作用的潜在分子基础。AngII显著增加了RINm5Fβ细胞系中MCP-1 mRNA和蛋白的表达,并激活了MCP-1启动子。AngII诱导的MCP-1 mRNA表达被1型AngII受体拮抗剂抑制,但2型AngII受体拮抗剂对其无影响。酪氨酸激酶抑制剂染料木黄酮抑制了AngII诱导的MCP-1表达,提示存在丝裂原活化蛋白激酶(MAPK)信号传导机制。AngII激活了细胞外信号调节激酶1/2(ERK1/2)的磷酸化,但未激活p38或c-Jun氨基末端MAPK。抑制ERK1/2激活可减少AngII诱导的MCP-1合成。在非肥胖糖尿病小鼠的胰腺中,血管紧张素转换酶表达的时间模式与胰岛炎和β细胞破坏的进展密切相关。胰腺连续切片的免疫染色显示,血管紧张素转换酶与MCP-1在胰岛β细胞中共定位。在从血糖正常的小鼠新鲜分离的胰岛中,AngII单独或与白细胞介素-1β联合作用,通过刺激MCP-1引发炎症反应。我们的数据表明,在胰岛炎期间,局部胰腺AngII生成系统存在正性自分泌/旁分泌作用,并首次深入了解了AngII启动的信号转导途径,该途径调节MCP-1,可能是胰岛中的一种炎症机制。